Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Ansun Biopharma Inc patents


Recent patent applications related to Ansun Biopharma Inc. Ansun Biopharma Inc is listed as an Agent/Assignee. Note: Ansun Biopharma Inc may have other listings under different names/spellings. We're not affiliated with Ansun Biopharma Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Ansun Biopharma Inc-related inventors


 new patent  Anti-viral therapeutic for infection of the eye

The present disclosure provides novel compositions and methods for treating an infection of the eye resulting from an infection of a member of the picornavirdae virus family. In particular, the present disclosure provides compounds having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by a pathogen, such as a virus. ... Ansun Biopharma Inc

Treatment of human metapneumovirus

The present disclosure provides compositions and methods for treating an infection by human metapneumovirus (hmpv). In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by hmpv.. ... Ansun Biopharma Inc

Methods, compounds, and compositions for treatment and prophylaxis in the respiratory tract

The present invention provides a method of reducing the quantity of mucus in the respiratory tract of a subject with elevated levels of mucus in said respiratory tract. The method includes administering to the subject a compound or composition containing a therapeutically effective amount of a fusion protein comprising a sialidase or an active portion thereof and an anchoring domain. ... Ansun Biopharma Inc

Technology for preparation of macromolecular microspheres

Microspheres are produced by contacting an aqueous solution of a protein or other macromolecule with an organic solvent and a counterion, and chilling the solution. The microspheres are useful for preparing pharmaceuticals of defined dimensions.. ... Ansun Biopharma Inc

Technology for the preparation of microparticles

Microspheres are produced by contacting a solution of a macromolecule or small molecule in a solvent with an antisolvent and a counterion, and chilling the solution. The microspheres are useful for preparing pharmaceuticals, nutraceuticals, cosmetic products and the like of defined dimensions.. ... Ansun Biopharma Inc

Novel class of therapeutic protein based molecules

The present invention provides new compositions and methods for preventing and treating pathogen infection. In particular, the present invention provides compounds having an anchoring domain that anchors the compound to the surface of a target cell, and a therapeutic domain that can act extracellularly to prevent infection of a target cell by a pathogen, such as a virus. ... Ansun Biopharma Inc

Treatment of infection by human enterovirus d68

The present disclosure provides compositions and methods for treating an infection by ev-d68. In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by ev-d68.. ... Ansun Biopharma Inc

Ecotin variants

Ecotin variants and their use in treating viral hemorrhagic fever are described. Described herein are methods for treating systemic inflammatory response syndrome or viral hemorrahagic fever by administering an ecotin polypeptide. ... Ansun Biopharma Inc

Methods, compounds and compositions for treatment of influenza and parainfluenza patients

A method of reducing or treating parainfluenza or influenza virus infection in an immunocompromised patient by administering to the respiratory tract of the patient a composition comprising a therapeutically effective amount of protein having sialidase activity.. . ... Ansun Biopharma Inc

Treatment of middle east respiratory syndrome coronavirus

The present disclosure provides novel compositions and methods for treating an infection by middle east respiratory syndrome coronavirus (mers-cov). In particular, the present disclosure provides methods that entail administering agents having an anchoring domain that anchors the compound to the surface of a target cell, and a sialidase domain that can act extracellularly to inhibit infection of a target cell by mers:cov.. ... Ansun Biopharma Inc

Technology for the preparation of microparticles

Microspheres are produced by contacting a solution of a macromolecule or small molecule in a solvent with an antisolvent and a counterion, and chilling the solution. The microspheres are useful for preparing pharmaceuticals, nutraceuticals, cosmetic products and the like of defined dimensions.. ... Ansun Biopharma Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Ansun Biopharma Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Ansun Biopharma Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###